KE Caudle
Impact in
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism
- Treatment of Major Depression
- Drug-Induced Adverse Reactions
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments
Papers in
- Pharmacology 12
- Pharmacogenetics and Drug Metabolism 12
- Drug-Induced Adverse Reactions 1
- Co-authors
- Teri E. Klein (10 shared papers)Stuart A. Scott (3 shared papers)Andrea Gaedigk (4 shared papers)Jesse Joachim Swen (3 shared papers)Katrin Sangkuhl (2 shared papers)Müller Dj (2 shared papers)J K Hicks (2 shared papers)Julia Stingl (2 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (11 papers)Figshare (1 paper)
- Partner nations
- United StatesJapanGermany
In The Last Decade
KE Caudle
12 papers receiving 3.5k citations
KE Caudle's Hit Papers
Peers
Comparison fields: 5 of 89
- Pharmacology 2.9k
- Transplantation 195
- Pharmacology 208
- Geriatrics and Gerontology 34
- Health Informatics 18
Countries citing papers authored by KE Caudle
This map shows the geographic impact of KE Caudle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by KE Caudle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites KE Caudle more than expected).
Fields of papers citing papers by KE Caudle
This network shows the impact of papers produced by KE Caudle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by KE Caudle. The network helps show where KE Caudle may publish in the future.
Co-authors
The 25 scholars most cited alongside KE Caudle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake Inhibitors Hit paper breakdown → | 2015 | 786 |
| 2 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing Hit paper breakdown → | 2015 | 574 |
| 3 | Clinical pharmacogenetics implementation consortium guideline (CPIC) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update Hit paper breakdown → | 2016 | 535 |
| 4 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for Pharmacogenetics‐Guided Warfarin Dosing: 2017 Update Hit paper breakdown → | 2017 | 526 |
| 5 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy Hit paper breakdown → | 2016 | 315 |
| 6 | 2017 | 197 | |
| 7 | 2015 | 186 | |
| 8 | 2016 | 180 | |
| 9 | 2015 | 139 | |
| 10 | 2015 | 132 | |
| 11 | Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants | 2025 | 7 |
| 12 | 2017 | 6 |
About KE Caudle
KE Caudle is a scholar working on Pharmacology, Pharmacology, Nuclear Energy and Engineering, Waste Management and Disposal and Infectious Diseases, having authored 12 papers that have together received 3.6k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (12 papers) and Drug-Induced Adverse Reactions (1 paper). The work is most often cited by research in Pharmacology (2.9k citations), Transplantation (195 citations), Pharmacology (208 citations), Geriatrics and Gerontology (34 citations) and Health Informatics (18 citations). KE Caudle has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Teri E. Klein, Stuart A. Scott, Andrea Gaedigk, Jesse Joachim Swen, Katrin Sangkuhl, Müller Dj, J K Hicks, Julia Stingl, Todd C. Skaar and Michelle Whirl‐Carrillo. Their work appears in journals such as Clinical Pharmacology & Therapeutics and Figshare.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.